Produktuen Katalogoa AASRAW

Produktuen Katalogoa AASRAW

Prohormone

4-DHEA (571-44-8) ≥98%

Adrenosterona ≥98%

Amp Citrate (71776-70-0) ≥98%

Cytomel (T3) ≥98%

Dymethazine (DMZ) ≥98%

Levothyroxina (T4) ≥98%

OL 135 (681135-77-3) ≥98%

Stanolone ≥98%

Trestolon azetatoa (MENT) ≥98%

Landare Extract

Nuciferine ≥98%

Bromelain ≥98%

PolipodiuM-a ateratzea ≥98%

Nootropics hautsa

Alpha GPC ≥98%

CDP choline ≥98%

Coluracetam ≥98%

Fasoracetam ≥98%

IDRA-21 (22503-72-6) ≥98%

Magnesioa L-treonata ≥98%

N-metil-D-aspartarraren azidoa (NMDA) ≥98%

Noopept (GVS-111) ≥98%

Fenilpiracetam (Carphedon) ≥98%

Pramiracetam ≥98%

Sunifiram (DM235) ≥98%

β-feniletilaminak HCL ≥%

Nikotinamida erribosido kloruroa% 98

β-Nikotinamida Mononukleotidoa% 98

Fat Loss hautsa

Adrenalina HCL ≥98%

Cetilistat (Oblean) ≥98%

Garcinia Cambogia ≥98%

IDFP (615250-02-7) ≥98%

L-carnitina ≥98%

Lorcaserin (Belviq) ≥98%

Lorcaserin HCL ≥98%

Methyltrienolone ≥98%

Orlistat ≥98%

Phaseolin ≥98%

Rimonabant ≥98%

Synephrine ≥98%

Sinephrine HCL ≥98%

I + G erreaktiboak

Apatinib (811803-05-1) ≥98%

Apixaban ≥98%

Afterpitant ≥98%

Arnika Montana ≥98%

Bevacizumab (216974-75-3) ≥98%

Bortezomib (179324-69-7) ≥98%

Buparlisib (944396-07-0) ≥98%

Azido kafeikoaren Fenetil Ester (CAPE) ≥98%

Canrenona (976-71-6) ≥98%

Cortexolone 17α-propionatoa ≥98%

Crizotinib (877399-52-5) ≥98%

Dolastatin 10 (110417-88-4) ≥98%

Entecavir hidrato ≥98%

Epacadostat (INCB024360) ≥98%

Eplerenona (107724-20-9) ≥98%

Etravirina ≥10%

Febuxostat (144060-53-7) ≥98%

Fosaprepitant dimeglumine (EMEND) ≥98%

Guggulsterone ≥98%

Homopiperazina ≥98%

Hydralazine HCL ≥98%

JP104 (887264-45-1) ≥98%

JW 642 (1416133-89-5) ≥98%

Ticagrelor (274693-27-5) ≥98%

LCZ696 (936623-90-4) ≥98%

Mitoxantrona HCL ≥98%

MMAD (Demethyldolastatin 10) ≥98%

MMAF (Hydrochloride) (1415246-68-2) ≥98%

E monometil auristatin (MMAE) ≥98%

N-Boc-dolaproine (120205-50-7) ≥98%

Nifuratel (4936-47-4) ≥98%

Obeticholic Acid ≥98%

Osimertinib (AZD-9291) ≥98%

Pyridoxal hydrochloride ≥98%

Pyridoxal fosfatoa ≥98%

Pyridoxal-5-fosfatoa monohidratoa ≥98%

Rivaroxaban ≥98%

Rocuronium bromuroa ≥98%

3-Methoxy-13-ethyl-gona-2,5 (10)-diene-17-ol ≥98%

N-phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide ≥98%

SARMS

AC 262356 ≥98%

BMS-564929 ≥98%

Cardarine (GW501516) ≥98%

LGD-2226 ≥98%

LGD3303 (1196133-39-7) ≥98%

LGD-4033 (VK5211) Ligandrol ≥98%

MK 677 (Ibutamoren) ≥98%

Ostarine (MK2866) ≥98%

PRL-8-53 ≥98%

RAD140 (Testolone) ≥98%

S4 (Andarine) ≥98%

Beste batzuk

2-aminoisoheptane (28292-43-5) ≥98%

Alprostadil, (PGE1), Prostaglandin E1 ≥98%

Dyclonine HCL ≥98%

Estra-4, 9-diene-3, 17-dione ≥98%

Everolimus (159351-69-6) ≥98%

Formestanoa (566-48-3) ≥98%

Fulvestrant (129453-61-8) ≥98%

Isoproterenol HCL (949-36-0) ≥98%

Isotretinoina ≥98%

Lapatinib (231277-92-2) ≥98%

L-Epinephrine HCL (55-31-2) ≥98%

Sorafenib (284461-73-0) ≥98%

Topiramatoa ≥98%

Trastuzumab (180288-69-1) ≥98%

Hormonas hobetzeko sexua

Avanafil ≥98%

Cyproterona azetatoa ≥98%

Dapoxetina HCL ≥98%

Dutasterida ≥98%

Finasterida ≥98%

Flibanserin ≥98%

Flibanserin HCL ≥98%

JinYang Alkali (Jinyang Base) ≥98%

Levonorgestrel ≥98%

Raloxifene ≥98%

Tadalafil (Cialis) ≥98%

Yohimbina HCL ≥98%

Minbiziaren aurkako

Acalabrutinib (ACP-196)

Afatinib (BIBW2992）

Ceritinib (LDK378)

Sunitinib Malate

Copyright © 2021 aasraw Eskubide guztiak erreserbatuta.

Ezespena: Ez dugu inolako erreklamaziorik egiten webgune honetan saltzen diren produktuei buruz. Webgune honetan emandako informaziorik ez du FDAk edo MHRAk ebaluatu. Webgune honetan ematen den informazioa guk dakigunaren arabera ematen da eta ez dago mediku profesional kualifikatuaren aholkuak ordezkatzeko helburuarekin. Gure bezeroek emandako testigantzak edo produktuen iritziak ez dira aasraw.com-en iritziak eta ez dira gomendio edo egitatzat hartu behar.

www.cofttek.com www.apicmo.com www.wisepowder.com www.phcoker.com www.scienceherb.com www.cmoapi.com www.apicdmo.com

Беларуская мова

Azərbaycan dili

বাংলা

Български

ქართული

Ελληνικά

ગુજરાતી

Ōlelo Hawaiʻi

עִבְרִית

हिन्दी

Bahasa Indonesia

ಕನ್ನಡ

Қазақ тілі

ភាសាខ្មែរ

Кыргызча

ພາສາລາວ

Latviešu valoda

Lietuvių kalba

Lëtzebuergesch

Македонски јазик

മലയാളം

मराठी

ဗမာစာ

नेपाली

ਪੰਜਾਬੀ

Српски језик

සිංහල

தமிழ்

తెలుగు

Українська

img.wp-smiley,img.emoji{display:inline !important;border:none !important;box-shadow:none !important;height:1em !important;width:1em !important;margin:0 .07em !important;vertical-align:-.1em !important;background:none !important;padding:0 !important;}#rs-demo-id{}.woocommerce form .form-row .required{visibility:visible;}@media only screen and (-Webkit-min-device-pixel-ratio: 1.5), only screen and (-moz-min-device-pixel-ratio: 1.5), only screen and (-o-min-device-pixel-ratio: 3/2), only screen and (min-device-pixel-ratio: 1.5){}.switcher{font-family:Arial;font-size:12pt;text-align:left;cursor:pointer;overflow:hidden;width:173px;line-height:17px;}.switcher a{text-decoration:none;display:block;font-size:12pt;-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;}.switcher a img{vertical-align:middle;display:inline;border:0;padding:0;margin:0;opacity:.8;}.switcher a:hover img{opacity:1;}.switcher .selected{background:#fff linear-gradient(180deg,#efefef 0%,#fff 70%);position:relative;z-index:9999;}.switcher .selected a{border:1px solid #ccc;color:#666;padding:3px 5px;width:161px;}.switcher .selected a:after{height:24px;display:inline-block;position:absolute;right:10px;width:15px;background-position:50%;background-size:11px;background-image:url("data:image/svg+xml;utf8,<svg xmlns=\'http://www.w3.org/2000/svg\' width=\'16\' height=\'16\' viewBox=\'0 0 285 285\'><path d=\'M282 76.5l-14.2-14.3a9 9 0 0 0-13.1 0L142.5 174.4 30.3 62.2a9 9 0 0 0-13.2 0L3 76.5a9 9 0 0 0 0 13.1l133 133a9 9 0 0 0 13.1 0l133-133a9 9 0 0 0 0-13z\' style=\'fill:%23666\'/></svg>");background-repeat:no-repeat;content:"" !important;transition:all .2s;}.switcher .selected a.open:after{-webkit-transform:rotate(-180deg);transform:rotate(-180deg);}.switcher .selected a:hover{background:#fff;}.switcher .option{position:relative;z-index:9998;border-left:1px solid #ccc;border-right:1px solid #ccc;border-bottom:1px solid #ccc;background-color:#eee;display:none;width:171px;max-height:198px;-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;overflow-y:auto;overflow-x:hidden;}.switcher .option a{color:#000;padding:3px 5px;}.switcher .option a:hover{background:#fff;}.switcher .option a.selected{background:#fff;}#selected_lang_name{float:none;}.l_name{float:none !important;margin:0;}.switcher .option::-webkit-scrollbar-track{-webkit-box-shadow:inset 0 0 3px rgba(0,0,0,.3);border-radius:5px;background-color:#f5f5f5;}.switcher .option::-webkit-scrollbar{width:5px;}.switcher .option::-webkit-scrollbar-thumb{border-radius:5px;-webkit-box-shadow:inset 0 0 3px rgba(0,0,0,.3);background-color:#888;}